Observatorio de Bioética, UCV

Genetic testing in women with a risk of tumour diseases


08 enero
12:44 2015

There is a passionate medical and ethical debate about whether genetic testing should be carried out on all women to detect whether they are carriers of BRCA genes, as carriers are known to have a much higher likelihood of developing breast cancer in adulthood. The topic was debated in a recent article in Annals of Internal Medicine (Ann Intern Med 160(4); 271-281, 2014), concluding that it should only be recommended in women with “family members who have breast, ovarian, tubal or peritoneal cancer”; however the aforementioned genetic test is not recommended in women with no family members with these types of cancers or mutations in the BRCA1 or BRCA2 genes.

Genetic testing in women with a risk of tumour diseases

Acerca del autor

Justo Aznar

Director del Instituto de Ciencias de la Vida de la UCV
Miembro de la Pontificia Academia para la Vida
Doctor en Médicina

Artículos relacionados

0 comentarios

Escribe un comentario

Su email no será publicado.
Los campos requeridos están marcados *